Fig. 5From: RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancerFunctional enrichment analysis between high-risk group and low-risk group. A Hallmark gene sets were quantified by “GSVA” and compared between high-risk group and low-risk group; B GSEA to explore the difference of pathway between high-risk group and low-risk group; C Cancer-related pathways presented significant survival difference in CESCBack to article page